← board
CURLF
distress 2/10 · well-funded / low risk$9.30-1%today-34% from 52w high
Revenue
$1268M
Liquidity
$104M
Runway
—
Shares 1y
+9%
Price & events
+19.2% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.7%
1D
-0.5%
1W
-1.8%
1M
+6.5%
3M
+14.4%
6M
+148.0%
1Y
-28.3%
2Y
-75.7%
5Y
-76.0%
All
Overview
- Market Cap
- $5.80B
- Enterprise Value
- $6.21B
- Volume
- 522
- 52 Week Range
- $3.00 – $14.10
- Total Shares
- 623.52M
- Float Shares
- 225.97M
- % Held by Insiders
- 25.80%
- % Held by Institutions
- 7.57%
- RVOL
- 0.00x
- Beta
- 1.64
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-05earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 623,520,125 · 0 offerings/1y · 0 PIPEs
- 2025-02-10EFFECTshelf_effective
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $15 (+61% upside) · 2 analysts
- 2024-08-08NeedhamBuy
Competitors
- none identified
Recent news
- 2026-07-14Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited - Investing News Network
- 2026-07-14Curaleaf Holdings (TSX: CURA) first to register standardized cannabis preparations in Spain - Stock Titan
- 2026-07-14Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited - Yahoo Finance
- 2026-07-13Curaleaf (CURLF) Achieves Milestone with Standardized Cannabis F - GuruFocus
- 2026-07-06Curaleaf opens marijuana dispensary on Airport Road in Lehigh County | Lehigh Valley Regional News - WFMZ.com
- 2026-07-01List of 18 Acquisitions by Curaleaf (Jul 2026) - Tracxn
- 2026-06-26Curaleaf to Report Second Quarter 2026 Financial and Operational Results – Company Announcement - Financial Times
- 2026-06-26Curaleaf to announce Q2FY26 results on August 5 - scanx.trade
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.